Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Medicines shortages

Proposals to change legislation to ensure drug supply in case of no-deal Brexit could 'pose risk to patient safety'

The Pharmacists’ Defence Association has warned that proposals to issue a “serious shortage protocol” would “open the door” to governmental interference in medicines supply.

Pharmacist selecting medicine box

Source: Shutterstock.com

If an amendment is made to the Human Medicines Regulations 2012, medicines could be dispensed in accordance with the serious shortage protocol rather than the prescription

Plans to alter the management of drugs supply in the case of a no-deal Brexit could make it possible to sanction medicines supply to patients in non-pharmacy locations, in the absence of any pharmacist input or usual safeguards, the Pharmacists’ Defence Association (PDA) has warned.

In December 2018, prompted by preparations for Brexit, the Department of Health and Social Care (DHSC) launched a consultation on enabling ministers to alter the Human Medicines Regulations 2012 to issue a “serious shortage protocol” in case of a national shortage.

Such a protocol would enable community pharmacists and other dispensers to dispense in accordance with the protocol rather than the prescription without having to contact a patient’s GP, including substituting medicines.

The government is also proposing that ministers should be able to continue to make changes to the Human Medicines Regulation 2012 in relation to serious shortages caused by the UK’s exit from the EU.

But the PDA has expressed concerns that the changes in legislation could “pose a risk to patient safety” and would “open the door” to governmental interference in medicines supply.

It also said that it would be time consuming for frontline staff to explain to patients why their medication has been changed if a medicine substitution is needed and that pharmacists would need to liaise with GPs about the changes to ensure continuity of care.

“We were concerned by the government’s view that no such pharmacist/GP liaison would be required and that, as a result, the changes would amount to a ‘positive impact’,” said the PDA in its response.

The PDA also highlighted that the government had “overlooked” the fact that other areas of legislation would need to be amended — namely, the Human Medicines Regulations 2012 Section 17 and the Medicines Act 1968 Section 64 — in order to make it lawful for a pharmacist to substitute a medicine.

It recommended that the government “ensure that safeguards are in place to prevent inappropriate use of serious shortage protocols for factors unrelated to EU withdrawal”.

A spokesperson for the DHSC said that it was currently reviewing the responses to the consultation and that any protocol would be developed and signed off by “highly specialised clinicians” to ensure the system is “robust and safe”.

“In the event of a shortage of any medicine it’s vital that patients continue to receive the high level of treatment they expect,” they said.

“These are sensible proposals that should reduce the time taken for alternatives to be provided to patients and make it easier for clinicians to deliver the appropriate treatment.”

The DHSC also said that, for a number of patients, including those with epilepsy, a serious shortage protocol would not be appropriate and, as a result, these individuals would not be affected by any changes to legislation.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20205976

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.